CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC
CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC
Latest treatments in oesophageal cancer
Final data from phase II study of eftilagimod alpha and pembro in PD-1/PD-L1 inhibitors resistant second line metastatic NSCLC
Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC
Intraoperative radiotherapy treatment in the Philippines
The importance of training to improve cancer care in the Philippines
PSMO and the future of cancer care in the Philippines
Low value practices that result in poor patient outcomes in LMICs
Key methods for handling difficult conversations in cancer care
Radiotherapy for multiple cancer types in the Philippines
Complementary and alternative medicine for cancer in the Philippines
The Choosing Wisely Philippines project and its impact